Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Wanda L, Salzer"'
Autor:
Erin M. Guest, John A. Kairalla, Joanne M. Hilden, ZoAnn E. Dreyer, Andrew J. Carroll, Nyla A. Heerema, Cindy Y. Wang, Meenakshi Devidas, Lia Gore, Wanda L. Salzer, Naomi J. Winick, William L. Carroll, Elizabeth A. Raetz, Michael Borowitz, Mignon L. Loh, Stephen P. Hunger, Patrick A. Brown
Publikováno v:
Haematologica, Vol 107, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/6f75c85ff88943d48d1cd90df26deea7
Autor:
Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A Heerema, Julie Gastier-Foster, Michael J Borowitz, Brent L Wood, Kelly W Maloney, Leonard A Mattano, Eric C Larsen, Anne L Angiolillo, Michael J Burke, Wanda L Salzer, Stuart S Winter, Patrick A Brown, Erin M Guest, Kimberley P Dunsmore, John A Kairalla, Naomi J Winick, William L Carroll, Elizabeth A Raetz, Stephen P Hunger, Mignon L Loh, Meenakshi Devidas
Publikováno v:
The Lancet Haematology. 10:e129-e141
Autor:
Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas, Yunfeng Dai, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patrick A. Zweidler-McKay, Michael J. Borowitz, Brent Wood, Nyla A. Heerema, Andrew J. Carroll, Naomi Winick, William L. Carroll, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
With modern chemotherapy, approximately 90% of patients with pediatric acute lymphoblastic leukemia are now cured. However, subsets of patients can be identified who remain at very high risk of relapse with expected 4-year disease-free survival rates
Externí odkaz:
https://doaj.org/article/400df5614bb0423c96a66827ab493ef8
Autor:
Kristina K. Hardy, John A. Kairalla, Anthony R. Gioia, Hannah S. Weisman, Meera Gurung, Robert B. Noll, Pamela S. Hinds, Emily Hibbitts, Wanda L. Salzer, Michael J. Burke, Naomi J. Winick, Leanne Embry
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Zhaohui Gu, Michelle Churchman, Kathryn Roberts, Yongjin Li, Yu Liu, Richard C. Harvey, Kelly McCastlain, Shalini C. Reshmi, Debbie Payne-Turner, Ilaria Iacobucci, Ying Shao, I-Ming Chen, Marcus Valentine, Deqing Pei, Karen L. Mungall, Andrew J. Mungall, Yussanne Ma, Richard Moore, Marco Marra, Eileen Stonerock, Julie M. Gastier-Foster, Meenakshi Devidas, Yunfeng Dai, Brent Wood, Michael Borowitz, Eric E. Larsen, Kelly Maloney, Leonard A. Mattano Jr, Anne Angiolillo, Wanda L. Salzer, Michael J. Burke, Francesca Gianni, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Anthony V. Moorman, Bella Patel, Adele K. Fielding, Jacob M. Rowe, Selina M. Luger, Ravi Bhatia, Ibrahim Aldoss, Stephen J. Forman, Jessica Kohlschmidt, Krzysztof Mrózek, Guido Marcucci, Clara D. Bloomfield, Wendy Stock, Steven Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Acute lymphoblastic leukaemia is characterized by chromosomal rearrangements. Here, the authors carry out RNA-sequencing on a large cohort of patients and identify recurrent rearrangements of MEF2D, which lead to increased transcriptional activity of
Externí odkaz:
https://doaj.org/article/a47717c88ef24c69ad243e26e4c2ed5d
Autor:
Sarah Alexander, Sumit Gupta, John Kairalla, Emily Hibbitts, Hannah Weisman, Doralina Anghelescu, Naomi J Winick, Kevin R. Krull, Wanda L Salzer, Michael J. Burke, Lia Gore, Meenakshi Devidas, Stephen P. Hunger, Mignon L. Loh, Kristina Hardy
Publikováno v:
Blood. 140:2179-2180
Autor:
Mignon L. Loh, Naomi J. Winick, Elizabeth A. Raetz, Eric Larsen, Karen R. Rabin, William L. Carroll, Stephen P. Hunger, Zhiguo Chen, Brent L. Wood, Wanda L. Salzer, Nyla A. Heerema, Michael J. Burke, Julie M. Gastier-Foster, Michael J. Borowitz, Andrew J. Carroll, Meenakshi Devidas
Publikováno v:
Leukemia
Adolescent and young adult (AYA) patients 16–30 years old with high-risk acute lymphoblastic leukemia (HR-ALL) have inferior outcomes compared to younger HR-ALL patients. AALL0232 was a Phase 3 randomized Children’s Oncology Group trial for newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d792ffb4fad053dab8e4d396bd999325
https://europepmc.org/articles/PMC9014378/
https://europepmc.org/articles/PMC9014378/
Autor:
Erin M, Guest, John A, Kairalla, Joanne M, Hilden, ZoAnn E, Dreyer, Andrew J, Carroll, Nyla A, Heerema, Cindy Y, Wang, Meenakshi, Devidas, Lia, Gore, Wanda L, Salzer, Naomi J, Winick, William L, Carroll, Elizabeth A, Raetz, Michael, Borowitz, Mignon L, Loh, Stephen P, Hunger, Patrick A, Brown
Publikováno v:
Haematologica. 107(5)
Autor:
Joanne M. Hilden, Mignon L. Loh, Stephen P. Hunger, Lia Gore, Elizabeth A. Raetz, Naomi J. Winick, William L. Carroll, Donald Small, John A. Kairalla, Cindy Wang, Wanda L. Salzer, Nyla A. Heerema, Zo Ann E. Dreyer, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll, Patrick A. Brown
Publikováno v:
Leukemia
Infants with KMT2A‐rearranged acute lymphoblastic leukemia (KMT2A-r ALL) have a poor prognosis. KMT2A-r ALL overexpresses FLT3, and the FLT3 inhibitor (FLT3i) lestaurtinib potentiates chemotherapy‐induced cytotoxicity in preclinical models. Child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936bfdc962c0b2ff7a0463ffafe7612c
https://europepmc.org/articles/PMC8763141/
https://europepmc.org/articles/PMC8763141/
Autor:
Melissa A. Richard, Meenakshi Devidas, Wenjian Yang, John P. Woodhouse, Vilmarie Rodriguez, Johann K. Hitzler, Reuven J. Schore, Anne L. Angiolillo, Michael J. Burke, Wanda L. Salzer, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger, Jun J. Yang, Philip J. Lupo, Karen R. Rabin
Publikováno v:
Cancer Research. 82:2002-2002
Background: Children with Down syndrome (DS) have an increased risk of acute lymphoblastic leukemia (ALL) and are more likely to experience morbidity and mortality from infectious toxicities during treatment compared to those without DS. We sought to